IIM
CMPX icon

INTECH Investment Management’s Compass Therapeutics CMPX Stock Holding History

INTECH Investment Management’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$61.1K Sell
27,910
-1,893
-6% -$5.59K ﹤0.01% 2030
2026
Q1 		$158K Sell
29,803
-9,133
-23% -$52.7K ﹤0.01% 1809
2025
Q4 		$209K Hold
38,936
– – ﹤0.01% 1961
2025
Q3 		$136K Sell
38,936
-5,287
-12% -$16.7K ﹤0.01% 2175
2025
Q2 		$115K Sell
44,223
-34,071
-44% -$70.3K ﹤0.01% 2260
2025
Q1 		$149K Buy
78,294
+26,370
+51% +$70.1K ﹤0.01% 2196
2024
Q4 		$75.3K Buy
51,924
+35,632
+219% +$59.2K ﹤0.01% 2270
2024
Q3 		$30K Buy
+16,292
New +$20.3K ﹤0.01% 2006

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

INTECH Investment Management's CMPX Position: Q2 2026 in Review

INTECH Investment Management reduced its Compass Therapeutics (CMPX) stake by 6.4% in Q2 2026, selling an estimated $5.59K and leaving 27,910 shares worth $61.1K. The position accounts for ﹤0.01% of the portfolio, ranked #2030.

INTECH Investment Management first reported a position in CMPX in Q3 2024 and has held it in 8 quarters since. The position peaked at $209K in Q4 2025. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • INTECH Investment Management held 27,910 shares of Compass Therapeutics worth $61.1K as of Q2 2026.
  • INTECH Investment Management sold 1,893 Compass Therapeutics shares in Q2 2026, an estimated $5.59K.
  • Compass Therapeutics made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #2030 holding.
  • INTECH Investment Management first reported a position in Compass Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • INTECH Investment Management's Compass Therapeutics position peaked at $209K in Q4 2025.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.